These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Raeburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE. Br J Pharmacol; 1994 Dec 15; 113(4):1423-31. PubMed ID: 7889300 [Abstract] [Full Text] [Related]
8. Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation. Souness JE, Carter CM, Diocee BK, Hassall GA, Wood LJ, Turner NC. Biochem Pharmacol; 1991 Jul 25; 42(4):937-45. PubMed ID: 1651083 [Abstract] [Full Text] [Related]
11. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors. Souness JE, Hassall GA, Parrott DP. Biochem Pharmacol; 1992 Sep 01; 44(5):857-66. PubMed ID: 1326964 [Abstract] [Full Text] [Related]
12. A comparison of the inhibitory activity of selective PDE4 inhibitors on eosinophil recruitment in guinea pig skin. Teixeira MM, Miotla JM, Cooper N, Gristwood RW, Hellewell PG. Mem Inst Oswaldo Cruz; 1997 Sep 01; 92 Suppl 2():193-6. PubMed ID: 9698932 [Abstract] [Full Text] [Related]
13. A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo. Cooper N, Teixeira MM, Warneck J, Miotla JM, Wills RE, Macari DM, Gristwood RW, Hellewell PG. Br J Pharmacol; 1999 Apr 01; 126(8):1863-71. PubMed ID: 10372831 [Abstract] [Full Text] [Related]
15. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim. Cortijo J, Villagrasa V, Navarrete C, Sanz C, Berto L, Michel A, Bonnet PA, Morcillo EJ. Br J Pharmacol; 1996 Sep 01; 119(1):99-106. PubMed ID: 8872362 [Abstract] [Full Text] [Related]
16. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Tenor H, Hatzelmann A, Church MK, Schudt C, Shute JK. Br J Pharmacol; 1996 Aug 01; 118(7):1727-35. PubMed ID: 8842438 [Abstract] [Full Text] [Related]
17. CDP840: a novel inhibitor of PDE-4. Perry MJ, O'Connell J, Walker C, Crabbe T, Baldock D, Russell A, Lumb S, Huang Z, Howat D, Allen R, Merriman M, Walls J, Daniel T, Hughes B, Laliberte F, Higgs GA, Owens RJ. Cell Biochem Biophys; 1998 Aug 01; 29(1-2):113-32. PubMed ID: 9631241 [Abstract] [Full Text] [Related]
18. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme. Silva PM, Alves AC, Serra MF, Pires AL, Silva JP, Barreto EO, Cordeiro RS, Jose PJ, Teixeira MM, Lagente V, Martins MA. Br J Pharmacol; 2001 Sep 01; 134(2):283-94. PubMed ID: 11564646 [Abstract] [Full Text] [Related]